New weapon tested against Tough-to-Treat blood cancer
Disease control
Recruiting now
This early-stage study is testing a new type of CAR-T cell therapy called LMY-920 for adults with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) that has returned or stopped responding to standard treatments. The therapy uses the patient's own modified imm…
Phase: PHASE1 • Sponsor: Paolo Caimi, MD • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC